To elaborate on the concept of superhuman vaccine immunity:
Each of the 3 examples in our piece are for different reasons. 1. HPV—best, since the human response is weak 2. Tetanus—small amounts of toxin don't elicit strong response) 3. H Flu—the bacterium is sugar coated
2/
This is different from vaccine efficacy.
Take measles. The natural human response to infection provides durable efficacy but the vaccine requires multiple shots and is without lifelong protection. 3/
Superhuman vaccine = superior to typical human response to natural infection
The #SARSCoV2 neutralizing antibody response to mRNA vaccines has exceeded that of many convalescent patients by orders of magnitude @NEJMbit.ly/33ys84T 4/
The natural human response to #COVID19 infection leaves many patients without a full and/or durable immune response, as nicely depicted (G=IgG, B=B cells, 4=CD4, 8=CD8, A=IgA) biorxiv.org/content/10.110… Figure 5C @profshanecrotty and colleagues 5/
Several #SARSCoV2 reinfections have been documented in patients without a sufficient IgG antibody response to the primary infection bnonews.com/index.php/2020… 6/
There are still many unknowns about the mRNA (and other platform) #SARSCoV2 vaccines with respect to durability, sterilization immunity (that would prevent transmission) and the role of T cells. 7/
In sum, the results to date suggest #SARSCoV2's spike protein lays the foundation for a potent vaccine-induced immune response that will turn out to be superior to that derived from natural infections. 8/
I recently spoke to @DrPaulOffit about the concept of a superhuman vaccine immune response medscape.com/viewarticle/93…
He highlighted the #SARSCoV2 inhibition of our interferon response and this point👇
And cited the 3 prototypic examples
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Three new @NEJM reports on #H5N1 today 1. An overview by @MichaelGIsonMD and @DrJeanneM
"urgent need for vigilant surveillance of emerging mutations and assessment of the threat of human-to-human transmission"
2. Report of the 13-year-old Canadian girl who developed acute respiratory failure. Sequence of her H5N1 revealed 3 mutations that may be linked to higher virulence and adaptation to human cell binding
3. Review of 46 cases of mild H5N1 illness by CDC in 2024
We're learning how to control the immune response, like a rheostat, even in the brain. Implications for understanding the basis and potential treatment of autoimmune conditions like multiple sclerosis, #LongCovid, #MECFS, and brain cancer.
A brief review of 6 recent, important reports
in the new Ground Truths, open-access
Such as Programming T cells with brain-specific proteins and payloads
@ScienceMagazine science.org/doi/10.1126/sc…
Or peptide fragments of myelin basic protein that suppress the immune response @Nature nature.com/articles/s4158…
New @NEJM
A whopping (~90%) reduction of progression to Type 2 diabetes with tirzepatide (GLP-1 drug, dual receptor) vs placebo in a randomized trial of >2,500 participants with obesity, absolute reduction of 10/100 treated
In other GLP-1 new publications today
—Country-wide Sweden reduced hospitalizations for alcohol or substance abuse with these drugs jamanetwork.com/journals/jamap… @JAMAPsych
—Concerns about discontinuation jamanetwork.com/journals/jama/… @JAMA_current
Other new anti-obesity drugs in the pipeline, one that also increases energy expenditure
@NatureNV nature.com/articles/d4158…
A dedicated issue of @ScienceTM on #LongCovid
—Sex-specific differences, with perspective by @VirusesImmunity and @SilvaJ_C
—Insights for therapies @AndreaCoxMDPhD
—Deconvoluting "Osler's Web" @MichaelPelusoMD @DeeksSteven @DrMaureenHanson @SaydahSharon
—+RECOVER Trial, Lyme disease
An elegant @Nature study by @AkassoglouLab has illuminated our understanding of the role of fibrin (component of blood clots), #SARSCoV2, and brain inflammation in Covid and #LongCovid.
This discovery and more in the new Ground Truths podcast, with transcript, key figures (such as as the one below) and citations. Open-access. Link in my profile.
A clip from our conversation. Unknowingly, @AkassoglouLab was gearing up for understanding this complex pathophysiology for many years before Covid hit
For treatment, it's not just as simple as preventing fibrin clots. It's isolating the pro-inflammatory action of fibrin, targeted by the antibody
Covid and increased risk of major adverse cardiovascular events (MACE) 3-years out
2-fold increased for any severity of Covid
~4-fold increase for Covid requiring hospitalization
"a coronary artery disease equivalent"
interaction with non-O blood types
@uk_biobankahajournals.org/doi/10.1161/AT…
"A major finding from our analyses was that the risk
of MACE among the subset of hospitalized COVID-
19 cases without known CVD (ie, primary prevention
patients) was comparable to (or even slightly higher than) the risk in patients with CVD, PAD, or diabetes but without COVID-19."
"one of the first examples of a gene-pathogen exposure interaction for thrombotic events"
I think it's the first one documented, likely others to be unraveled